Nuclera Rating A · Worker

Nuclera is a biotechnology and healthcare company that develops rapid protein prototyping technologies. Its main product is the eProtein Discovery system, an automated benchtop platform that combines cell-free protein synthesis with digital microfluidics. This system enables researchers to perform in-house protein design, screening, characterisation, and expression within a short timeframe.

The company serves sectors such as drug discovery, structural biology, and academic research. Its technology automates parallel screens to identify soluble, high-yield proteins and antibody fragments in less than forty-eight hours, replacing slow, iterative manual laboratory methods with a digital workflow.